[1]
D. Abgottspon and B. Ernst, “In vivo Evaluation of FimH Antagonists – A Novel Class of Antimicrobials for the Treatment of Urinary Tract Infection”, Chimia, vol. 66, no. 4, p. 166, Apr. 2012.